Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation—A meta-analysis
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,General Medicine
Reference29 articles.
1. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence;Issa;Am J Nephrol,2013
2. Immunomodulation in inflammatory neuropathies: rationale and safety;Jacob;Curr Drug Saf,2013
3. Role of mizoribine in renal transplantation;Tsuzuki;Pediatr Int,2002
4. Revival of effective and safe high-dose mizoribine for the kidney transplantation;Sugitani;Clin Transplant,2006
5. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection;European Mycophenolate Mofetil Cooperative Study Group;Lancet,1995
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mizoribine Promotes Molecular Chaperone HSP60/HSP10 Complex Formation;International Journal of Molecular Sciences;2024-06-12
2. The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis;Computational Intelligence and Neuroscience;2022-07-22
3. Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine;CEN Case Reports;2022-06-24
4. Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study;Therapeutic Advances in Musculoskeletal Disease;2022-01
5. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China;BMC Nephrology;2021-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3